Arcus Biosciences, Inc. (RCUS)
Latest RCUS Insider Trades
About Arcus Biosciences, Inc. (RCUS)
Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.
- HAYWARD, CA
- 601
- 2018
- XNYS
90-Day SEC Filing Activity
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 8 | 102,827 | $2.99M |
| Grant or award | 14 | 158,200 | |
| Option exercise | 4 | 73,834 |
RCUS Insider Transactions (Form 4)
2446 Form 4 filings on record, the earliest from Dec 4, 2024, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Ii Robert C. Goeltz - Officer | Open-market sale | Common Stock | 5,000 |
Recent RCUS Form 8-K Filings
5Recent RCUS Form 144 Notices of Proposed Sale
3A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| ALEXANDER AZOY | Officer | 2,827 | $83K | View on EDGAR | |
| - | - |
RCUS Insider Trading - FAQ
What is the latest insider trade for RCUS?
Arcus Biosciences, Inc. (RCUS) had 11 insider filings in the last 90 days, with the most recent on 2026-08-24. The full record for RCUS runs to 46 Form 4 filings, the earliest from 2024-12-04. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying RCUS stock?
No insider purchases of RCUS were filed in the last 90 days.
How many insiders are selling RCUS stock?
8 insider sales of RCUS were filed in the last 90 days, totaling $2.99M.
Where can I see RCUS SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks RCUS Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow RCUS insider buys?
Create a free InsiderAlpha account and press Watch on this page to add RCUS to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity
Recent Insider Filings
10Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
- - Alexander Azoy view on EDGAR
- - Juan C. Jaen view on EDGAR
- - Juan C. Jaen view on EDGAR
- - Nicole Lambert view on EDGAR
- - Patrick Machado view on EDGAR
- - Yasunori Kaneko view on EDGAR
- - Carolyn C. Tang view on EDGAR
- - David L. Lacey view on EDGAR
- - Kathryn E. Falberg view on EDGAR
Related Companies - Recent Insider Activity
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity in Health Care
- Where RCUS's peers are being bought and sold.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track RCUS insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
